
Cassiar asbestos mine, near Yukon-B.C. border, one of province's most contaminated: mining watchdog
The Cassiar asbestos mine in B.C. closed back in 1992, but decades later, the B.C. Mining Law Reform Network says it remains among the most polluted mine sites in the province.
The mine recently made the organization's 2025 Dirty Dozen list. Co-chair Nikki Skuce said the network is increasingly hearing from former workers with health issues.
"Lung diseases and asbestos-related diseases, which are pretty deadly and awful, have a latency period of 10 to 40 years," she said.
Asbestos — minerals that can cause serious health concerns if breathed in — can no longer be imported, sold or used in Canada. Organizations like WorksafeBC say it still kills more workers in the province than anything else. Some workers and residents from the former Cassiar mine site have died from different lung diseases since the mine shuttered.
The site was taken over in 2003 by Cassiar Jade Contracting Inc., which purchased the mine's operating permit for $1 under the condition it would take on $50,000 worth of reclamation work annually. The company is now mining the site for jade.
Skuce said she is concerned about whether unsafe conditions persist at the mine.
"What are the precautions they're undertaking for that reclamation so they're not also exposing new people to asbestos?" she said.
Cassiar Jade president Tony Ritter said the mining and reclamation work performed at the site isn't dangerous.
"There's many safety regulations and stuff we would have to follow, and you know, working there now, we follow them," Ritter said. "There's provisions to make sure it's absolutely safe and nobody's exposed to anything that would be harmful to them.
"Throughout the history of the mine there and Cassiar, it was very safe," he added. When asked about reports of former workers with cancer, Ritter said it's not clear there's a connection to the mine.
"I couldn't say, I'm not a doctor," he said. "I certainly hope not, otherwise I would probably be pretty sick by now."
'Nobody ever told us it was dangerous'
Rose Peregoodoff grew up in Cassiar, just over 80 kilometres south of the Yukon border. Both her parents worked at the Cassiar mine.
"He was a drill blast foreman, so he was the guy that made the big bang," she said. "He was front and centre where they would blow up the mountaintop … and all that dust and everything … he would be inhaling."
She said he later developed asbestosis as well as mesothelioma, a cancer associated with exposure to asbestos.
"My mother used to shovel asbestos," she said. "Whatever fell off the conveyor belt in the mine drive, the ladies would shovel back onto the belt.
"So my mother was right there too, buried in asbestos. Now she has major lung problems. And, you know, we don't know if it's from the asbestos or not."
Peregoodoff said many children who lived in the town ended up being exposed as well. Former residents of Cassiar have described the clouds of dust from the mine that would fall on the town, covering the snow with a layer of green.
"We used to use it as papier mâché to make art projects in school," she said. "Heck, we used to play in the tailings pile. We'd slide down it in the summer with little boards and pretend we were sliding down a big snow hill."
Years later, as more and more people she knows have health issues, the idea that her lungs could be a ticking time bomb is always in the back of her mind.
"Nobody ever told us it was dangerous," she said. "In school, they would come in with these little trays and they'd have these different pieces of asbestos in there, and they'd say we're doing really well [at the mine]. These fibres are long, they're not going to be an issue when you're older."
In fact, studies have found that exposure to longer fibres actually increases the risk of lung cancer — although both long and short chrysotile asbestos fibres are toxic.
"We ate the snow when we were kids," Peregoodoff added. "Every kid eats snow. So how much asbestos did we ingest?"
Skuce said if people like Peregoodoff — who weren't employed by the mining company — develop health issues, it can be difficult for them to get support.
"One former resident we talked to grew up there eating snow covered in asbestos dust," she said. "Folks like him are left unable to get WorkSafeBC claims."
Progress of remediation efforts
Twenty years after the mine's sale, Cassiar Jade Contracting was fined $40,000 for failing to provide a reclamation plan to the province and repeatedly failing to comply with inspection orders, including occupational health and safety requirements.
During a hearing with the province, a manager with the Watson Lake-based company stated that shutdown orders from inspectors following asbestos exposure concerns stopped work at the site for around a year.
Ritter also told CBC that difficulties brought on by COVID, as well as a company they hired to complete the plan, created delays with the report, but said that reclamation work is underway.
The company eventually submitted a reclamation and closure plan in 2024. A few months later, the B.C. Ministry of Energy and Mines issued an order that will effectively end jade mining in northwestern B.C., citing challenges around permitting, compliance and enforcement in the remote region. The company has since launched a lawsuit against the province.
Peregoodoff believes regulators should have stepped in sooner to deal with the asbestos tailings pile at the site.
"Now, when the big winds come along and blow that dirt and dust everywhere, it's still contaminating the area," said Peregoodoff. "Like who knows what it's doing to the animals there and all the Tlingit and Tahltan and Kaska people that hunt up there."
"I'm sure there's some valid concerns there," said Ritter, when asked about Peregoodoff's concerns and the mine site's inclusion in the B.C. Mining Law Reform Network's list. "And to me, that would be another benefit [of continuing]."
Ritter said there is magnesium in the tailings pile that could be recovered and "enhance the reclamation process." They're also testing for copper and other minerals at the site.
Today, Cassiar, B.C., is a ghost town. But Ritter hopes the company's activities will spark new life in the region — and bring jobs to the neighbouring communities of Dease Lake in B.C and Watson Lake in the Yukon.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CTV News
37 minutes ago
- CTV News
SickKids Hospital seeing ‘tremendous increase' in e-scooter injuries, doctor says
SickKids is raising the alarm bell on the rise of injuries bringing kids and teens through the ER related to e-scooters. SickKids is raising the alarm bell on the rise of injuries bringing kids and teens through the ER related to e-scooters. Emergency medicine physician Dr. Daniel Rosenfield weighs in. Rise of injuries bringing kids and teens through the ER related to e-scooters An emergency room doctor at Toronto's SickKids Hospital says physicians are already seeing a 'tremendous increase' in both the number and severity of e-scooter injuries this year. Dr. Daniel Rosenfield told CP24 on Tuesday morning that the emergency department at SickKids saw 16 e-scooter injuries in the month of May alone. Rosenfield said this marks the continuation of a concerning trend that the downtown hospital has seen in recent years. According to SickKids, there were 16 e-scooter injuries in June and July of last year, up from just five in June and July of 2023. 'We've seen major head injuries, major inter-abdominal injuries, significant fractures,' Rosenfield said. 'The majority of the injuries we've seen are head injuries and 80 per cent of our users have not been wearing helmets when they had these injuries.' Rosenfield said the most severe injuries included significant facial fractures and internal bleeding. Some resulted in hospital and even ICU admission. 'The speeds that these scooters can reach so quickly, the acceleration that's found within these, much like an electric car, is unlike anything we've ever seen,' he said. 'My six-year-old on his scooter with his foot power cannot get anywhere near the speeds these kids get at two and three seconds.' Recent hospital data from 2020 to 2024 found that about 25 per cent of patients at SickKids who presented with e-scooter injuries were admitted for serious injuries. Rosenfield said experts do not recommend e-scooter use for anyone under the age of 16, adding that anyone riding one should wear a helmet to prevent serious injuries in the event of a collision. 'We are really lucky that we haven't seen any fatalities to date, but I honestly think as this trend continues, there is a good possibility that could occur.'

CBC
an hour ago
- CBC
Sudbury long-term care home still can't admit new residents, six months after provincial order issued
Social Sharing A long-term care home in Sudbury has not been able to admit new residents for six months now, following a provincial order. The Ontario Ministry of Long Term Care issued what it calls a Cease Admissions Order on December 16, 2024. This means no new residents can move into the nursing home while the order remains in place. The order came after residents and families made numerous complaints about care at the home, which opened in May 2024 on Algonquin Road in the city's south end. Provincial inspectors issued six compliance orders after finding standards were not being met under Ontario's Fixing Long-Term Care Act. The those orders have since been lifted, but follow-up inspections at Extendicare Countryside since December have found some of the same issues are ongoing. The latest inspection report published by the ministry on June 4 comes from an on-site inspection between May 5 and May 9. These types of inspections are regular check-ins to identify any non-compliance with provincial standards and do not cover complaints or critical issues, which are investigated separately. Following the inspection, five written notifications were given to Extendicare Countryside for non-compliance. These include issues with skin and wound care, including failing to ensure that the care a resident received was documented. The home was also notified about staff not responding to the needs of a resident and not properly cleaning the dining area. In a statement to CBC News, Extendicare Countryside said the written notifications "are not unexpected or unusual for any Ontario long-term care home. This is helpful feedback that allows us to focus on areas that require additional effort or improvement." Extendicare added it continues to address gaps and improve care and is encouraged by the home's continued progress. Despite that, families and residents have continued to voice their concerns in recent months, with Sudbury-area New Democrat MPPs Jamie West and France Gélinas calling for a full inspection of the nursing home.


Globe and Mail
an hour ago
- Globe and Mail
Analysts Say AI Could Add $100B+ to Healthcare—But Most Systems Aren't Ready
Issued on behalf of Avant Technologies Inc. VANCOUVER – News Commentary – A growing chorus of political and academic voices is calling AI the defining force behind the next evolution in healthcare. Former UK Prime Minister Tony Blair recently warned that failing to embrace AI-driven doctors and nurses could leave entire nations behind, while London Business School professor Nicos Savva echoed the sentiment in Forbes, framing AI as essential to future-ready care. Meanwhile, a new Wolters Kluwer report highlights a troubling disconnect: while interest is surging, most healthcare organizations remain unprepared to deploy GenAI tools at scale. Yet even as institutions scramble to catch up, key breakthroughs are already coming from innovators like Avant Technologies, Inc. (OTCQB: AVAI), Palantir Technologies (NASDAQ: PLTR), Astrana Health, Inc. (NASDAQ: ASTH), Tempus AI, Inc. (NASDAQ: TEM), and SoundHound AI, Inc. (NASDAQ: SOUN). Analysts at McKinsey now estimate that generative AI could generate up to $110 billion in annual value across pharma and medical products alone. Statista projects the broader AI healthcare market will surge from $11 billion today to $188 billion by 2030 — a leap that signals just how quickly the landscape is changing. Avant Technologies, Inc. (OTCQB: AVAI) has just taken a major step forward in its evolution from AI incubator to full-stack healthcare innovator. Today, the company announced it had signed a non-binding letter of intent to acquire 100% of Ainnova Tech, its joint venture partner and the developer of the Vision AI diagnostic platform. Prior to the acquisition, the two companies have been operating jointly through Ai-nova Acquisition Corp (AAC), which holds global licensing rights to Ainnova's technology portfolio and serves as the commercialization engine for Vision AI and all future device deployments. 'We believe bringing the two companies together will offer tremendous value for shareholders, it will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally,' said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of AAC. 'We feel the joint venture has been a success and both companies have worked well together toward a common goal, so we believe that we can be even more successful and use our resources more effectively as one company to further AI in healthcare.' Under the proposed agreement, Ainnova would roll all of its outstanding equity into the combined public entity — unifying leadership and eliminating structural complexity ahead of a scheduled FDA pre-submission meeting in July. While final terms of the deal are still being negotiated, both companies say the merger would streamline commercialization and accelerate the rollout of Ainnova's flagship Vision AI technology — a platform already in use across clinical sites in Latin America for the early detection of diabetic retinopathy, cardiovascular disease, and other chronic conditions. The move also signals growing confidence from Avant's leadership as they prepare to bring proprietary hardware into the mix. In parallel with the merger discussions, Avant and Ainnova are entering the final prototyping stage of a low-cost, automated retinal imaging device — marking a potential turning point in the companies' shared push toward AI-powered early diagnostics. The new device is designed to operate hands-free and feed imaging data directly into the Vision AI platform, enabling near-instant risk reports without expensive equipment or trained personnel. The companies say the camera, developed under their joint venture Ai-nova Acquisition Corp. (AAC), is expected to cost a fraction of legacy fundus cameras. By combining affordability with automation, the device could expand screening access across primary care clinics and emerging-market providers that have traditionally been priced out of ophthalmic diagnostics. 'The cost of a fundus camera has always been a barrier to entry in this market,' said Vargas. 'Our low-cost camera, which is a fraction of the cost of currently available cameras on the market, should allow us to not only enter the market, but to capture a large share of the market.' Also in development are additional platform modules, including a patented dementia detection tool that combines a five-minute blood test with AI-trained algorithms. Although that technology remains in evaluation, the core platform continues to expand its reach and functionality — evolving from a retinal-focused application into a broader engine for predictive healthcare. 'Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily,' said Vargas in a previous statement. 'We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem. To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions.' As the camera prototype nears completion, Avant is positioning itself for broader market entry. While a launch date has yet to be announced, the integrated platform is designed to reduce diagnostic friction, speed up referrals, and expand access to early-stage health insights — especially in geographies where affordability, not innovation, remains the primary barrier to care. Palantir Technologies (NASDAQ: PLTR) has partnered with TeleTracking Technologies to bring real-time AI-driven insights to hospitals and health systems. 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach,' said Alex Karp, CEO at Palantir. 'Helping to streamline operations allowing for increased focus on providing the best level of care.' By integrating TeleTracking's Operations IQ platform with Palantir's Foundry and AIP tools, the collaboration will enable smarter resource management, predictive forecasting, and near-instant operational decision-making. The combined platform is designed to improve patient flow, reduce staff burden, and drive measurable gains in both care outcomes and financial performance. Astrana Health, Inc. (NASDAQ: ASTH) recently announced a wave of leadership appointments as the company accelerates its national rollout of an AI-driven, value-based care model. The most notable addition is Sherry McBride, a seasoned Medicare Advantage operator who joins as COO to lead integration and execution across Astrana's growing platform. 'We are thrilled to welcome Sherry, along with other recent executive hires and promotions, to the leadership team at a time of immense growth and opportunity for Astrana,' said Brandon Sim, President and CEO of Astrana Health. 'Her deep experience in delegated value-based care will further strengthen our ability to drive consistent, coordinated, high-quality patient outcomes at scale.' Other hires include a new Chief Data and Analytics Officer, Chief Accounting Officer, and Chief People Officer — a signal of Astrana's broader push to deepen capabilities across every operational tier. With a footprint spanning over 12,000 providers and more than a million patients, Astrana is preparing to scale smart, coordinated care on a national level. Tempus AI, Inc. (NASDAQ: TEM) has expanded its generative AI clinical assistant, Tempus One, with direct integration into EHR systems, allowing physicians to query data and streamline workflows in real time. 'As healthcare faces rising costs and growing complexity, no group bears the burden more heavily than physicians and care teams,' said Ryan Fukushima, Chief Operating Officer at Tempus. 'This evolution of Tempus One represents a meaningful shift from a world where clinicians spend countless hours searching for answers and documenting care, to one where AI rapidly connects the dots across fragmented systems to deliver actionable insights in real time.' The platform now includes embedded ASCO guidelines, appointment prep tools, and intelligent note-taking — reducing administrative burden and improving decision-making in oncology and beyond. Tempus is also rolling out its Agent Builder tool to select providers, enabling custom GenAI solutions integrated directly into clinical practice. SoundHound AI, Inc. (NASDAQ: SOUN) has partnered with Allina Health to launch 'Alli,' an AI-powered voice agent designed to streamline patient access and reduce administrative bottlenecks. "One of our key goals is to make sure that we're providing a market-leading patient experience," said David Ingham, DO, Chief Information Officer of Allina Health. "Alli is an extension of our team, and we're excited to have her on board to streamline operations, reduce wait times, and deliver a faster, more seamless experience for our patients." Built on the Amelia conversational AI platform, Alli integrates with Allina's EHR system to authenticate callers, manage appointments, and soon handle tasks like refilling medications or answering non-clinical questions. "Long wait times and administrative complexity can be a huge source of stress for patients," said Michael Anderson, Executive Vice President of Enterprise AI at SoundHound AI. "We are proud to partner with Allina Health on this important digital transformation. The organization is taking a forward-thinking approach by integrating AI to support patients with immediate, personalized assistance." Early results show improved call efficiency and faster response times, enabling staff to focus on complex patient needs. CONTACT: cs@ (250) 999-4849 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of Media Corp. ('BAY') BAY has been not been paid a fee for Avant Technologies Inc. advertising and/or digital media, but the owner(s) of BAY also own Market IQ Media Group, Inc., which has been paid a fee from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of BAY own shares of Avant Technologies Inc. which were purchased in the open market. BAY and all of it's respective employees, owners and affiliates reserve the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by BAY has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.